Literature DB >> 12615367

Increased interleukin-6 and granulocyte-macrophage colony stimulating factor levels in the sera of patients with non-segmental vitiligo.

Cai Xia Tu1, Jin Song Gu, Xi Ran Lin.   

Abstract

BACKGROUND: Although the cause of vitiligo is unknown, an autoimmune theory has been proposed, and there is now convincing evidence that cytokines have an important role in pathogenesis of autoimmunity.
OBJECTIVE: To study the possible role of interleukin-1, beta (IL-1 beta), interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor-alpha (TNF-alpha) and granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of vitiligo.
METHODS: The authors measured the serum levels of the above-mentioned cytokines from 50 patients with the vitiligo compared with 20 healthy volunteers, employing the method of radioimmunoassay.
RESULTS: The results showed that the serum levels of both IL-6 and GM-CSF of the patients with both focal type and generalized type of vitiligo, and the serum level of IL-1 beta of the generalized type,were significantly, higher than those of normal controls in the patients with segmental vitiligo, the serum levels of all the cytokines tested were not significantly different from those of the normal controls. The GM-CSF levels of both focal type and generalized type, and the IL-6 level of the generalized type in progressive stage were significantly higher than those in stable state.
CONCLUSION: It is speculated that IL-6 and GM-CSF may be involved in the autoimmune mechanism of non-segmental vitiligo. However, more evidence is required before a definite conclusion can be drawn.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615367     DOI: 10.1016/s0923-1811(02)00151-2

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  17 in total

1.  Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo.

Authors:  R Dey-Rao; A A Sinha
Journal:  Genes Immun       Date:  2015-11-12       Impact factor: 2.676

2.  Epidermal permeability barrier recovery is delayed in vitiligo-involved sites.

Authors:  J Liu; W Y Man; C Z Lv; S P Song; Y J Shi; P M Elias; M Q Man
Journal:  Skin Pharmacol Physiol       Date:  2010-02-25       Impact factor: 3.479

Review 3.  Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo.

Authors:  John E Harris
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

4.  Can monocyte to HDL cholesterol ratio and monocyte to lymphocyte ratio be markers for inflammation and oxidative stress in patients with vitiligo? A preliminary study.

Authors:  Abdullah Demirbaş; Ömer Faruk Elmas; Mustafa Atasoy; Ümit Türsen; Torello Lotti
Journal:  Arch Dermatol Res       Date:  2020-08-20       Impact factor: 3.017

5.  The role of cytokines in the pathomechanism of cutaneous disorders.

Authors:  Arijit Coondoo
Journal:  Indian J Dermatol       Date:  2012-03       Impact factor: 1.494

6.  Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8.

Authors:  Siavash Toosi; Seth J Orlow; Prashiela Manga
Journal:  J Invest Dermatol       Date:  2012-06-14       Impact factor: 8.551

Review 7.  Inflammasomes: current understanding and open questions.

Authors:  Franz Bauernfeind; Andrea Ablasser; Eva Bartok; Sarah Kim; Jonathan Schmid-Burgk; Taner Cavlar; Veit Hornung
Journal:  Cell Mol Life Sci       Date:  2010-10-31       Impact factor: 9.207

Review 8.  Stability in Vitiligo: Is there a Perfect Way to Predict it?

Authors:  Kanika Sahni; Davinder Parsad
Journal:  J Cutan Aesthet Surg       Date:  2013-04

9.  CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis.

Authors:  Jilong Wu; Miaoni Zhou; Yinsheng Wan; Aie Xu
Journal:  Mol Med Rep       Date:  2012-10-08       Impact factor: 2.952

10.  Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study.

Authors:  Brenda A Jensen; Rebecca J Leeman; Jennifer J Schlezinger; David H Sherr
Journal:  Environ Health       Date:  2003-12-16       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.